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ABSTRACT
Aizoon canariense, Cynomorium coccineum,
Glossonema edule, and Malva parviflora, edible
desert plants from Qatar, were selected to determine levels of phenolic bioactives and potential
health benefits for managing early stages of type 2
diabetes and hypertension. Aqueous extracts of C.
cocineum, contained soluble phenolics and had
relatively high levels of antioxidant activity associated with α-glucosidase, α-amylase, and angiotensin-converting enzyme (ACE). G. edule and M.
parviflora had moderate levels of anti-oxidant potential, soluble phenolics, and ACE inhibitory
activity. The medicinal properties associated with
C. coccineum suggest the plant may have potential
as a diet-based solution for combating, preventing,
and managing the early stage of type 2 diabetes
when coupled with an overall healthy life style and
pharmacological management strategies.
INTRODUCTION
Type 2 diabetes mellitus is a systemic, multilayered chronic disease with worldwide impact,
reaching epidemic proportions and projected to be the
7th leading cause of death by 2030 (WHO, 2013).
Qatar is predicted to have the highest number of
diabetic patients in the near future, with a reported
increase of 130% by the year 2030 (Mushlin et al.,
2012). Due to genetic susceptibility, children that
have one or two diabetic parents are two to four times
22

higher risk for being diagnosed with type 2 diabetes
(Harrison et al., 2003). Consanguinity, the incidence
of which is the highest in the State of Qatar (51%), is
frequently the cause of the prevalence of many
genetic disorders and other inherited adult diseases,
such as diabetes (Bener et al., 2013). In recent years,
many edible food, medicinal, and spice plants have
been investigated for potential benefits in managing
type 2 diabetes (Kaur et al., 2015; Mirmiran et al.,
2014).
Among the most important plant-based
antioxidants are the dietary phenolics that are thought
to be more effective as an antioxidants than vitamin E
or C in vitro and in vivo (Rice-Evans et al., 1997)
because they potentially have direct enzyme
inhibitory benefits as targets for hyperglycemia and
managing carbohydrate metabolism. Specifically,
apart from the antioxidant properties, phenolic
compounds are natural inhibitors of α-glucosidase
and α-amylase enzymes applicable for the
management of early stages of hyperglycaemia
associated with type 2 diabetes.
A method available for the management of type
2 diabetes is to impede the breakdown and intestinal
absorption of glucose through the inhibition of
pancreatic α-amylase and intestinal α-glucosidase
enzymes (Pinto et al., 2009). The presence of the
phenolics that act as α-glucosidase and α-amylase
inhibitors in fruits, vegetables and spices could be a
good approach to control post-prandial hyper-
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glycemia and provide effective benefits without side
effects. Further, many plants are also reported to be
anti-hypertensive mainly for their potential to inhibit
angiotensin converting enzyme (ACE) (Castro et al.,
2000), which can be targeted for managing
macrovascular complications of type 2 diabetes.
In the current study, phenolic bioactives from
four traditional edible plants from Qatar were
analysed for their potential in inhibiting αglucosidase, α-amylase and ACE using in vitro assay
models. In addition, the relevant total phenolic content, antioxidant potential and the different types of
phenolic compounds and their content were analyzed
using high performance liquid chromatography
(HPLC). The studied food plants were once a part of
the diet of the local Qatari population, but have been
largely replaced by imported provisions. Establishing
and incorporating the anti-diabetic potential of local
food into diets could help in manage this disease.

MATERIALS AND METHOD
Plant samples. Indigenous plants, Cynomorium
coccineum (local name: Trathuth), Aizoon canariense
(local name: Jafna), Glossonema edule (local name:
Yerawa), and Malva parviflora (local name:
Khobeza) were collected locally and identified by a
faculty member in the Department of Biological and
Environ-mental Sciences, Qatar University, Doha.
Porcine pancreatic α-amylase (EC 3.2.1.1), rat
intestinal α–glucosidase (EC3.2.1.20), hippuric acid,
rabbit lung ACE (angiotensin I-converting enzyme)
(EC 3.4.15.1), 2,2-diphenyl-1-picrylhydrazyl (DPPH),
acarbose, and ascorbic acid were purchased from
Sigma Chemical Co. Standards for gallic acid were
also purchased from Sigma Chemical Co.
Sample extraction. The edible portions of the
selected plants were extracted with water to determine the chemical constituency. For A. canariense
and M. parviflora, the entire plants were macerated
before extraction. For the C. coccineum, the inner
flesh of the stem was removed and then extracted.
The fruit of G. edule were cut into small pieces with a
cheese grater and then uniformly mixed before
extraction. All samples (2.5 g) were extracted in 100
mL of distilled water under reflux at 95oC for 30 min.
Each of the samples was subsequently centrifuged at

11,000 g for 10 min to separate cellular debris from
the extract.
Soluble phenolics. Total soluble phenolics in
each of the test samples were determined using a
previously established assay (Kwon et al., 2006). In
brief, a 0.5 mL of sample extract was weighed and
added to a test tube. Each of the samples in the test
tubes was subsequently mixed with 1 mL of 95%
ethanol, 5.5 mL of distilled water, and 0.5 mL of 50%
Folin-Ciocalteu reagent. After five minutes, 1 mL of
5% sodium carbonate was added to stop the reaction
and the absorbance of the mixture was determined at
725 nm using a UV-visible light spectrophotometer
(Agilent Model 8453) after a 1 h dark incubation.
Gallic acid was used as a standard, and the results
were expressed as µg gallic acid/mL of sample fresh
weight.
Antioxidant activity. The antioxidant activity
was determined using a DPPH radical scavenging
method modified from Kwon et al. (2006). A 250
L aliquot of the sample extract was mixed with 1.25
mL of DPPH (60 M in ethanol) and then centrifuged
at 5000 g for one minute. The absorbance was
measured at 517 nm using the previously
described Agilent UV-visible light spectrophotometer.
The absorbance readings were compared with a
control containing 95% ethanol in place of the sample
extract. The inhibition was calculated as:

-Amylase inhibition. The -amylase inhibitory activity was determined using a modified assay
of that described in the Worthington Enzyme Manual
(Worthington, 1993; Kwon et al., 2006). A total of
500 L of 0.02 M sodium phos-phate buffer (pH 6.9
with 0.006 M NaCl) containing 0.5 mg/mL of amylase were pre-incubated at 25oC for 10 min.
After the pre-incubation, 500 µL of a 1% starch
solution in 0.02 M sodium phosphate buffer (pH 6.9
with 0.006 M NaCl) was added to each tube at timed
intervals. The reaction was stopped using 1.0 mL of
dinitrosalicylic (DNS) acid color reagent. The test
tubes were incubated in a boiling water bath for 5
min and then cooled to room temperature. The
23
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reaction mixture was diluted by adding 5 to15 mL of
distilled water, and the absorbance was measured at
540 nm using the previously described UV-Visible
light spectrophotometer. The absorbance readings
were compared with the controls that contained
buffer instead of sample extract. The percentage amylase inhibitory activity was calculated using the
same equation used for percentage inhibition in the
DPPH radical inhibition assay.
-Glucosidase.
Inhibitory activity of glucosidase was measured following a modified
procedure described by McCue et al. (2005). The glucosidase was assayed using 50 L of sample
extracts and 100 L of 0.1 M phosphate buffer (pH
6.9) containing -glucosidase solution (1 U/mL),
which was then incubated in 96-well plates at 25°C
for 10 min. After the pre-incubation period, 50 L of
5 mM p-nitrophenyl--d-glucopyranoside solution in
0.1 M phosphate buffer (pH 6.9) was added to each
well at timed intervals. The reaction mixtures were
incubated at 25°C for 5 min.
Before and after incubation, absorbance
readings of the samples were recorded at 405 nm
using a microplate reader (Semi-Automated ELISA
System, TECAN SUNRISE Reader, Model Sunrise,
Austria) and compared with a control that had 50 L
of buffer solution in place of the extract. The glucosidase inhibitory activity was expressed as
percent inhibition and was calculated using the same
equation used for determining the percent inhibition
in the DPPH radical inhibition assay.
Dose
dependency was tested using 0.5 µL to 25 µL
following the same protocol.
ACE inhibition. ACE inhibition was assayed
by a method modified by Kwon et al. (2006), using
hippuryl-histidyl-leucine (HHL) as a substrate and
the ACE-I enzyme from rabbit lung (EC 3.4.15.1). A
volume of 50 L of sample extracts was incubated
with 100 L of 1 M NaCl-borate buffer (pH 8.3)
containing 2 mU of ACE-I solution at 37°C for 10
min. After pre-incubation, 100 L of a 5 mU substrate (HHL) solution was added to the reaction
mixture. Test solutions were incubated at 37°C for 1
h. The reaction was stopped with the addition of 150
L of 0.5 N HCl to the reaction.
24

A 5 L sample of the stopped reaction mixture
was injected into a high-performance liquid chromatography (HPLC) apparatus (Agilent 1100 with UVDetector 1100, Autosampler 1200 & Column compartment 1200, Agilent Technologies, Palo Alto,
CA). The solvents used for the gradient were 10 mM
phosphoric acid (pH 2.5) and 100% methanol. The
methanol concentration was 60% for the first 8 min
and then increased to 100% for 5 min followed by a
decrease to 0% for the next 5 min (total run time of
18 min). The analytical column was an Agilent
Nucleosil 100-5C18, 250 mm x 4.6 mm inside
diameter, filled with packing material of 5 m
particle size, and used a flow rate of 1 mL/min at
ambient temperature. During each run, the
absorbance was recorded at 228 nm for the detection
of liberated hippuric acid and retention time by
comparison with a calibration standard of hippuric
acid. The percentage inhibition was calculated using
a formula similar to that used for determining the
inhibition of for antioxidant activity of α-amylase.

HPLC analysis of phenolics. For analysis of
phenolics by HPLC, a 2 mL samples of the extracts
were filtered (pore size, 0.2 μm), and 5 μL was
injected into the HPLC apparatus (Agilent 1100 with
UV-Detector 1100, Auto-sampler 1200 and Column
compartment 1200, Agilent Technologies, Palo Alto,
CA). For gradient elution, the solvents were: 10 mM
phosphoric acid (pH 2.5) and 100% methanol. The
methanol concentration was increased from 0 to 60%
for the first 8 min and to 100% over the next 7 min,
then decreased to 0% for the next 3 min and
maintained for the next 7 min (total run time of 25
min).
The analytical column, an Agilent Zorbax SBC18, 250 mm x 4.6 mm i.d. packed with 5 μm
particle size, used a flow rate of 1 mL/min at ambient
temperature. Absorbance was recorded at 306 nm.
Calibration standards were cinnamic acid, rosmarinic
acid, protocatechuic acid, p-coumaric acid,
chlorogenic acid, caffeic acid, ferulic acid, gallic
acid and quercetin.
Extract constituents were
identified by comparison of retention times and diode

Phoboo et al.: In Vitro Assays of Anti-diabetic and Anti-hypertensive Potential

array spectral characteristics with the standards. The
results were expressed as L/g of sample fresh
weight.
Statistical analysis. Statistical analysis was a
one-way analysis of the variance (ANOVA). Posthoc comparisons were done using LSD test or a
planned comparison in SPSS version 16.0. (p < 0.05).
RESULTS AND DISCUSSION
Antioxidant activity, soluble phenolics, and
HPLC analysis. The total antioxidant activity and
total soluble phenolics of all four edible plants of
Qatar showed significantly different results (Figure
1). Cynomorium coccineum had significantly higher
antioxidant activity and total soluble phenolics as
comparison with the other three plants. Glossonema
edule had high antioxidant activity, but moderate
total soluble phenolics, whereas Malva parviflora and
Aizoon canariense had low antioxidant activity and
low total soluble phenolic content.
Figure 1. Total soluble phenolics and DPPH inhibitory
potential of plants1.

1Data

are mean ± SE (n=9). Columns with different letters indicate
statistically significant differences among groups at p<0.5. The
Pearson’s correlation coefficient between total soluble phenolics
and DPPH inhibitory potential was 0.79.

Among the studied edible plants, Cynomorium
coccineum is of particular interest in for the medicinal
applications in ancient times. Zucca et al. (2013)
evaluated both the aqueous and methanolic extracts
of C. coccineum for total antioxidant capacity using
selected ET-based methods, such as DPPH assay and

ABTS-based assay to measure the Trolox Equivalents
Antioxidant Capacity (TEAC), and the FRAP method
and ORAC assay based on pyrogallol red. Significant
antioxidant capacities using DPPH assay and ORACPYR assays were observed. Gao (2011) has reported
that the extract of another species of Cynomorium, C.
songaricum, contains proanthocyanidins that improve
DPPH free-radical scavenging activity.
Jin et al. (2014) has noted that the antioxidant
potential of acetone extract of C. songaricum, which
contains catechins, is significantly superior antioxidant activity compared with Vitamin E, but is
inferior to ascorbic acid. Nuo et al. (2010) has
reported high DPPH and ABTS free-radical scavenging activity by C. songaricum polysaccharides. Lu et
al. (2004) investigated the antioxidant effects of
aqueous extract C. songaricum in vitro on five types
of edible oils, and reported that soybean oil possessed
antioxidant capacity.
Zhao et al. (2009) has
described the antioxidant capacity of phenolic
compounds isolated from C. songaricum, which has a
stronger antioxidant effect at a concentration of
0.2596 mg/mL when compared with vitamin C.
In the current study, Malva parviflora had low
DPPH inhibitory activity and low total soluble
phenolics content. Although aqueous extracts were
used, the results agreed with a report by Afolayan et
al. (2008) indicating the methanolic extract of M.
parviflora had 9.3% DPPH inhibition and the
methanol extract inhibited 94.3% ABTS (2,2`-azinobis
[3-ethylbenzothiazoline-6-sulfonic acid] diammonium
salt) radical ion. Farhan, et al. (2012) reported aqueous and ethanolic extracts at 4 mg/mL of crude leaves
and stems of M. parviflora grown in Lebanon have
high DPPH inhibitory activity, enhancing the scavenging activity by 59% and 70%, respectively. The
current study, however, does not support the findings
of Farhan et al. (2012), but this could be due to
differences in extraction methods, genetic variation in
the edible plants, growing conditions, or assay
methodology.
The investigation of hydroxycinnamic acids
and other phenolic acids has not previously been
investigated in the four species of plants studied in
this report. Using HPLC chromatography, the current
25
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study demonstrated the presence of various phenolic
acids, such as gallic acid, chlorogenic acid, caffeic

acid, protocatechuic acid, and cinnamic acid, along
with quercetin in all four edible Qatari plant samples

Table 1. Phenolic compounds in aqueous extracts of plants.

Phytochemical

Cynomorium
Malva
Aizoon
Glossonema
coccineum
parviflora
canariense
edule
-------------------- (L /L) -------------------1,2
Gallic acid
8.12 ± 0.29a
1.61 ± 0.42bc
2.30 ± 0.59b
0.67 ± 0.23c
Chlorogenic acid
5.56 ± 0.29a
2,18 ± 0.14b
2.47 ± 0.27b
0.49 ± 0.12c
Caffeic acid
0.94 ± 0.17a
0.80 ± 0.10a
2,23 ± 0.46b
0.49 ± 0.11a
ac
ab
c
Protocatechuic acid 3.51 ± 0.66
2.50 ± 0.51
5.42 ± 1.09
0.77 ± 0.29b
Cinnamic acid
5.95 ± 0.95a
3.54 ± 0.60a
4.28 ± 0.71a
0.01 ± 0.01b
a
b
-----Quercetin
1.51 ± 0.42
4.13 ± 0.55
2.08 ± 0.45ab
1

Means ± standard error, n=9.
Means with different letters within rows are significantly different, p<0.05..

2

Cynomorium coccineum, in general, had higher
amounts of the phenolic phytochemicals. The gallic
acid content (8.12 L/L) was highest in C.
coccineum, whereas quercetin content was highest in
Malva parviflora (4.13 L/L). Protocatechuic acid
and cinnamic acid content were highest in Aizoon
canariense at 5.42 L/L and 5.95 L/L, respectively.
Zucca et al. (2013) also has reported the presence of
gallic acid in the extracts of C. coccineum. Rizk et al.
(1990) reported the presence of flavonoids, mainly
apigenin, 6,8 di-C-glucoside, and luteolin 7-Oglucoside, in unripe fruit of Glossonema edule,
whereas A. canariense has been reported to contain
alkaloids, coumarins, saponins, tannins, flavonoids,
steroids, and triterpenes. In a study by Farhan et al.
(2012) the methanolic fractions of polyphenols from
leaves and stems of M. parviflora contained different
amounts of phenolic compounds, flavonoids,
saponins, alkaloids, resins and tannins.

-Glucosidase/amylase inhibition. Based on
the in vitro assay model, only Cynomorium
coccineum extracts inhibited α-glucosidase and αamylase enzymes. Aqueous extract of C. coccineum
demonstrated a relatively high α-glucosidase inhibitory activity (Table 2). In contrast, a moderate
inhibition of α-amylase was observed in the aqueous
extracts of C. coccineum where 300 µL of extract
caused a 54.4% inhibition (Fig. 2). -Amylase and
α-glucosidase are key enzymes involved in starch
breakdown and subsequent glucose release leading to
rapid intestinal absorption. When inhibited by a high
26

carbohydrate diet, these enzymes are beneficial in
maintaining the postprandial blood sugar level and
managing hyperglycemia (Puls et al., 1977). A major
drawback of currently used -glucosidase and amylase inhibitors, such as pharmacologically
beneficial acarbose, are side effects, such as
abdominal distention, flatulence, tympanitis, and
diarrhea. These side effects are possibly due to
complete inhibition of -amylase, leaving the
carbohydrate to ferment in the colon (Bischoff et al.,
1985; Bischoff, 1994).
Table 2. α-Glucosidase inhibitory potential
of C. coccineum aqueous extract.
Doses

Inhibition (%) ±SE

10 µl
15 µl
20 µl
25 µl
30 µl

96.02 ± 0.05
96.92 ± 0.21
95.75 ± 0.06
96.13 ± 0.15
95.89 ± 0.07

35 µl
40 µl
50 µl

95.81 ±0.25
95.46 ±0.10
95.53 ± 0.21

Thus, integrating natural inhibitors from dietary
edible plants with lower inhibitory effects against αamylase activity and a stronger inhibitory activity
against α-glucosidase can be potentially targeted as a
more complimentary and effective therapy for
postprandial hyperglycemia control with minimal
side effects (Kwon et al. 2006). The result of this in
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vitro study indicates a biochemical rationale for why
C. coccineum has the potential to be highly effective
in modulating sugar uptake with a potentially
moderate effect on rapid starch break-down.

Data are mean % ± SE values (n=9). a-dColumns
with different letters indicate statistically significant
differences among groups at p < 0.05.

ACE inhibition assay. In an in vitro assay, the
aqueous extracts from Cynomorium coccineum,
Glossonema edule, and Malva parviflora inhibited
ACE inhibitory activity, but the aqueous extracts of
Aizoon canariense did not inhibit ACE. Of the three
studied plants, an aqueous extract of C. coccineum
had a higher ACE inhibitory action, 38.46 ± 3.38%,
than Glossonema edule, 27.81 ± 0.96% inhibition,
and Malva parviflora, 11.12 ± 6.06 % inhibition. The
long-term, macrovascular complications of diabetes
is hypertension. ACE is an important enzyme in
maintaining vascular tension through the activation of
and conversion of histidyl-leucine dipeptide to
angiotensin II, a vasoconstrictor (Skeggs et al. 1956).
Angiotensin II leads to stimulated synthesis and
release of aldosterone, increasing blood pressure by
retaining sodium in the distal tubules (Lieberman
1975). Inhibiting ACE is considered a beneficial
therapeutic approach in the treatment of high blood
pressure in both diabetic and non-diabetic patients.

CONCLUSIONS
The current study indicates a strong possibility
that Cynomorium coccineum, an edible spice and
food plant used in Qatar, could help manage glucose
and glucose-induced high levels of reactive oxygen
species (ROS) linked to hyperglycemia and type 2
diabetes-associated hypertension. To our knowledge,
studies on anti-diabetic potential of Cynomorium
coccineum, Aizoon canariense, and Glossonema
edule have not previously been studied.
Cynomorium
coccineum
which
grows
throughout the Mediterranean region, including North
Africa, the Arab peninsula, and beyond, is an edible
food and medicinal plant, commonly eaten during
famines and prized for medicinal properties. The
high antioxidant potential, indicated by the strong
DPPH inhibitory potential, plus the total soluble
phenolics, potent α-glucosidase inhibition, moderate
α-amylase inhibition, and ACE inhibiting potential,
indicate that Cynomorium coccineum can be used as
an edible source for preventing and managing the
early stages of type 2 diabetes. The -glucoside
inhibitory activity in the extract of Cynomorium
coccineum suggest that further investigation of this
activity will be worthwhile, including a comparative
study with acarbose, the α-glucosidase inhibitory
clinical drug.
The moderate antioxidant potential and total
soluble phenolics and ACE inhibitory potential
demonstrated by Malva parviflora and Glossonema
edule may also be useful for potentially managing
hypertension and oxidation-linked vascular complications. Indeed, additional studies may validate the
biochemical rationale of traditional edible food plants
and overall health benefits of plants that were
historically an important part of the Qatari diet.
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